INS and Hyperinsulinemia: Vamorolone did not induce hyperinsulinemia as a precursor of insulin resistance, which is consistent with recent human Phase 1 data where no changes in blood insulin and glucose levels were observed up through the highest dose (20 mg/kg/d) tested (Hoffman et al, 2018).